Clinical Trials Logo

Arrhythmias, Cardiac clinical trials

View clinical trials related to Arrhythmias, Cardiac.

Filter by:

NCT ID: NCT06455644 Recruiting - Clinical trials for Cardiovascular Diseases

Accuracy of LAA Occluder Size Selection: CT vs. DSA During Combined AF Ablation and LAA Occlusion

Start date: July 2024
Phase: N/A
Study type: Interventional

This study is a prospective, multi-center, randomized controlled trial. The subjects are patients scheduled to undergo a combined procedure of atrial fibrillation (AF) ablation and left atrial appendage (LAA) occlusion. After signing the informed consent form, the subjects will be randomly assigned to either the cardiac Computed Tomography (CT) group or the Digital Subtraction Angiography (DSA) group. The operator will select the appropriate LAA occluder size for implantation based on different measurement methods. All subjects will undergo clinical follow-up before discharge and at 3 months postoperatively, as well as telephone follow-up 1-5 years after the surgery.

NCT ID: NCT06452589 Not yet recruiting - Atrial Arrhythmias Clinical Trials

The Field PULSE Study

Start date: July 2024
Phase: N/A
Study type: Interventional

This is a pre-market, first-in-human, pilot, interventional, clinical investigation that aims to evaluate safety and feasibility of the FieldForce™ Ablation system in patients with atrial fibrillation who are indicated for an AF catheter ablation.

NCT ID: NCT06449599 Recruiting - Postoperative Pain Clinical Trials

Rhomboid Intercostal Block in Cardioverter Defibrillator Implantation (ICD)

Start date: June 4, 2024
Phase: N/A
Study type: Interventional

ICD implantation can be painful procedure even under local anesthesia and sedation. In this prospective-randomised study, ultrasound-guided rhomboid intercostal block will be performed to reduce intraoperative and postoperative pain. Also comfort of patients and the cardiologists will be evaluated. In this way, we expect to reduce possible complications and make this procedure more comfortable for patients and clinicians.

NCT ID: NCT06431828 Recruiting - Atrial Fibrillation Clinical Trials

Remote Symptom Review in Patients With Implantable Diagnostic Holter

BIOMONI-DIG
Start date: April 22, 2024
Phase: N/A
Study type: Interventional

To study the clinical and organizational benefit of implementing a methodology for monitoring patients receiving an implantable diagnostic BIOMONITOR III holter and successive models, consisting of remote review of alerts sent by the device via the HOME MONITORING remote monitoring platform and the transmission of relevant patient symptoms through the use of a specific application installable on the patient's phone. The efficiency of this methodology will be compared with a control group consisting of monitoring through the usual clinical practice of the hospital.

NCT ID: NCT06425887 Not yet recruiting - Arrythmia Clinical Trials

Smartwatch Paroxysmal Arrhythmia Detection Compared With Holter

Start date: July 1, 2024
Phase:
Study type: Observational
Read more »
NCT ID: NCT06414447 Not yet recruiting - Arrythmia Clinical Trials

Electrocardiogram (ECG) Validation Study

Start date: May 2024
Phase:
Study type: Observational

Comparison of diagnostic Electrocardiogram (ECG) signals

NCT ID: NCT06411392 Recruiting - Clinical trials for Ventricular Arrythmia

SBRT for Ventricular Arrhythmia

Start date: March 1, 2024
Phase: N/A
Study type: Interventional

The aim of this study is to demonstrate the safety and efficacy of STAR (Stereotactic Antiarrhythmic Radiotherapy) in patients with VT (ventricular tachycardia) who are unresponsive to standard treatments. Additionally, the planned study aims to provide further insights into the effects of STAR on VT burden, ICD interventions, and insights regarding late toxicities, particularly those related to the heart, which are currently not well understood.

NCT ID: NCT06409533 Recruiting - Atrial Fibrillation Clinical Trials

Rate Control Efficacy in Atrial Fibrillation With Rheumatic Mitral Stenosis: Lenient vs Strict Rate Control Strategies

RACE-MS
Start date: March 1, 2023
Phase: N/A
Study type: Interventional
Read more »
NCT ID: NCT06407154 Recruiting - Stroke Clinical Trials

Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures: an Observational Study, 2nd Wave

CLIMATE-II
Start date: May 21, 2024
Phase:
Study type: Observational

The CLIMATE-II Observational Study examines to what extent chronically ill patients experience adverse health effects because of heat and whether the patients' specific health behavior, somatosensory amplification, risk and benefit perception, self-efficacy, health literacy, degree of urbanisation of the patients' administration district and characteristics of the patients' neighborhood are associated with these effects.

NCT ID: NCT06402617 Recruiting - Atrial Fibrillation Clinical Trials

Ablation of Focal Activation in Atrial Fibrillation

RETRO-AF
Start date: April 30, 2024
Phase: N/A
Study type: Interventional

Recurrent focal electrical activation (or ectopy) superseding sinus activation is the only mechanism proven to drive paroxysmal atrial fibrillation (AF). However, it has not been possible to show similar focal drivers during AF, owing to the limitations of mapping in persistent AF. RETRO-Mapping has been developed as a method to generate activation maps during AF to test the hypothesis that persistent AF is also maintained by focal drivers. RETRO-Mapping is able to locate sites of focal activation that were isolated, intermittent, or recurrent during persistent AF. However, a 30-second segment of AF can have approximately 150 wavefronts in a small area of myocardium. Screening for focal activation and manually validating these prior to ablation was not feasible using current commercial systems. RETRO-Mapping can automatically detect focal activation and a recording system that enables the intracardiac signals to be directly analysed by the RETRO-Mapping software. This will allow RETRO-Mapping to build a detailed classification of focal activation types and study the impact of ablation of these sites on the AF cycle length, to address the hypothesis that persistent AF is maintained by focal drivers.